CLIA waiver clearance allows Binx to facilitate single visit testing for CT/NG in any of the more than 220,000 locations across the Unites States holding a CLIA certificate of waiver.
Read More
HHS will invest $10 billion to ramp up screening testing to help schools reopen and $2.25 billion to scale up testing in underserved populations, and provide new guidance on asymptomatic screening testing in schools, workplaces, and congregate settings.
Read More
The new guidance removes barriers to covid-19 diagnostic testing and vaccinations and strengthens requirements that plans and issuers cover diagnostic testing without cost sharing.
Read More
The LumiraDx Platform simplifies, scales down, and integrates techniques used in laboratory analyzers to provide lab-comparable diagnostic tests on a single point-of-care instrument.
Read More
Ceres Nanosciences’ facility will be capable of generating a supply of the company’s Nanotrap Magnetic Virus Particles to enable more than 10 million covid-19 tests per month.
Read More